EGFR and lung adenocarcinoma: Another study has shown that resistin activates Toll-like receptor 4 (TLR4) and engages with the Src pathway which activated the EGFR phosphorylation and increased epithelial-mesenchymal transition (EMT), subsequently inducing the migration and invasion of lung adenocarcinoma [13].